The International Regulome Consortium IRC announced today it has signed a non-binding letter of intent with Invitrogen Corporation (NASDAQ: IVGN) to develop tools for stem cell research that will aid in the development of new therapies for some of the world's most debilitating diseases. The agreement was signed here...
NeoStem, Inc. (AMEX: NBS), a leading-edge biotechnology company capitalizing on breakthroughs in the burgeoning field of adult stem cell therapeutics, has expanded its collection center network to Henderson, NV. The first official collection of adult stem cells in Nevada using NeoStem's process will occur during the Grand Opening on...
IRVINE, Calif., June 12 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products for cardiac revascularization, today announced a scientific presentation that describes the use of the PHOENIX delivery system combining transmyocardial revascularization TMR with autologous bone marrow derived stem cells.
Cornell University, including the Ithaca and New York City medical college campuses, received nearly $2 million in grants to conduct stem cell research, according to a release from Gov. Eliot Spitzer.
SAN DIEGO -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN), a biotechnology company focused on stem cell cryogenics and disposable stem cell/tissue transfer instruments, announced today it has entered into a contract with Validation Systems, Inc. to complete and finalize its FDA Good Manufacturing Practices cGMP Quality Systems documentation. Once this documentation...
The House Appropriations Committee has approved a $10 million increase in funding for stem cell research for next year, but a Senate subcommittee disagreed, deciding that expanding the program would be fiscally irresponsible in the face of a budget deficit.
John Wiley & Sons (Hoboken, NJ) will begin the preliminary online publication of "Current Protocols in Stem Cell Biology" with an issue in June. Online installments will continue through the end of 2007 and regular print and online mont John Wiley & Sons (Hoboken, NJ) will...
New York City-based NeoStem Inc., a publicly traded company specializing in adult stem cell production for use in controversial anti-aging therapies, opened a collection and storage center this month at the California Healthspan Institute in Encinita New York City-based NeoStem Inc., a publicly traded company ...
OCEANSIDE, Calif. -- International Stem Cell Corporation (OTCBB:ISCO), announced today a new collaboration with the University of Cambridge UK as part of ISCO's ongoing strategy to work with scientific leaders across the world to expand the scientific data relating to parthenogenetic stem cells.
NEW BRUNSWICK, N.J. & NEW YORK & PETACH TIKVAH, Israel -- BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the Company has expanded its collaboration with Rutgers University in an effort to cure spinal cord injuries through BrainStorm's...
SAN DIEGO -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN), a biotechnology company focused on stem cell cryogenics and disposable stem cell / tissue transfer instruments, announced today that Clean Rooms West has started the installation process of its modular class 10,000/100 Stem Cell Processing laboratory. Bio-Matrix Scientific is now entering into...
Shares in Stem Cell Sciences SCS received a shot in the arm this week, rising 2 per cent to 47.5p, after the company signed a deal with Merck. The Scottish stem-cell specialist has licensed its mouse neural stem-cell technology to the US drug giant Shares in...
More Stem Cell Research: More than 300 scientists from UC San Diego and Australia will be collaborating on stem cell research, the groups announced last week. Details of the collaboration were rough. While neither group announced any formal financ More Stem Cell Research:...
IRVINE, Calif. -- In a breakthrough for stem cell research and cellular replacement therapies, PrimeGen Biotech LLC (www.primegenbiotech.com) today announced that this week, its researchers will present data showing the isolation and therapeutic reprogramming of adult human germ line stem cells. Derived from adult stem cells but with the advantageous...
NEW YORK -- A world renowned leader in adult-derived stem cell research, The University of Pittsburgh and their Office of Enterprise Development OED will be facilitating "Speed Dating" at the 7th International Stem Cell Conference, being held Oct. 29-30, 2007, in Pittsburgh, PA. For full conference details, please visit www.almevents.com/stemcell.
Healtheuniverse Inc. (PINKSHEETS: HLUN), a biotechnology development firm specializing in the development and commercialization of biopharmaceutical and biomedical products, announced today that it featured a seminal presentation for the applications of adult stem cell technology. The presentation was in Singapore at NGS National University of Singapore Center for Life...
HOUSTON -- Stem Cell Innovations (OTCBB:SCLL), a cell biology company that has developed technology capable of creating a broad range of human stem cells from patented, pluripotent germ cells, today announced Tony Coelho is joining its board of directors.
Stem Cell Therapy International, Inc. (OTCBB: SCII), a leading stem cell research company operating international treatment clinics, announced today that it has been contacted by representatives for companies in India, Australia and Indonesia regarding acquiring the technology and license rights to SCII's new "no scars" stem cell treatment for burn...
SAN DIEGO -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN), a biotechnology company focused on stem cell cryogenics and disposable stem cell / tissue transfer instruments, announced today an update on the construction and installation of its new Stem Cell Class 10,000 Processing Laboratory.